Literature DB >> 35485436

Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: No.

Emma C Tallantyre1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35485436     DOI: 10.1177/13524585221091404

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  1 in total

1.  Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: Commentary.

Authors:  Jan Lycke; Anders Svenningsson
Journal:  Mult Scler       Date:  2022-07       Impact factor: 5.855

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.